ClinicalTrialsFinder

Bile Duct Adenocarcinoma Non-Resectable Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

HER2 Gene MutationBile Duct Adenocarcinoma Non-Resectable
Zhejiang Cancer Hospital28 enrolled1 locationNCT06383533